Company
Hansa Biopharma AB
Hansa Biopharma AB has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Imlifidase | Phase 2 | Kidney Transplantation in Highly Sensitized Patients |
Latest
No recent events.
Follow Hansa Biopharma AB on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.